RU2005113167A - ANTI-TUMOR COMBINATIONS CONTAINING PROTEINS AND CHEMOTHERAPEUTIC MEDICINES - Google Patents

ANTI-TUMOR COMBINATIONS CONTAINING PROTEINS AND CHEMOTHERAPEUTIC MEDICINES Download PDF

Info

Publication number
RU2005113167A
RU2005113167A RU2005113167/15A RU2005113167A RU2005113167A RU 2005113167 A RU2005113167 A RU 2005113167A RU 2005113167/15 A RU2005113167/15 A RU 2005113167/15A RU 2005113167 A RU2005113167 A RU 2005113167A RU 2005113167 A RU2005113167 A RU 2005113167A
Authority
RU
Russia
Prior art keywords
containing proteins
combinations containing
combination
chemotherapeutic medicines
tumor
Prior art date
Application number
RU2005113167/15A
Other languages
Russian (ru)
Inventor
Альберто БАРТОРЕЛЛИ (IT)
Альберто Барторелли
Даниэла КОНКАС (IT)
Даниэла КОНКАС
КИРРА Адальберто АРКАИ (IT)
КИРРА Адальберто АРКАИ
Карло МОР (IT)
Карло МОР
Original Assignee
ЦЕТЕЗИС С.п.А. (IT)
ЦЕТЕЗИС С.п.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ЦЕТЕЗИС С.п.А. (IT), ЦЕТЕЗИС С.п.А. filed Critical ЦЕТЕЗИС С.п.А. (IT)
Publication of RU2005113167A publication Critical patent/RU2005113167A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Physiology (AREA)
  • Virology (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Claims (4)

1. Фармацевтические композиции, содержащие:1. Pharmaceutical compositions containing: а) перхлорные экстракты печени козла, содержащие белок UK 114,a) perchloric extracts of goat liver containing UK 114 protein, б) циклофосфамид,b) cyclophosphamide, в) доксорубицин или другие антрациклины,c) doxorubicin or other anthracyclines, г) 5-фторурацил,g) 5-fluorouracil, в форме комбинации для одновременного, раздельного или последовательного применения в химиотерапии.in combination form for simultaneous, separate or sequential use in chemotherapy. 2. Применение белка UK 114 или содержащих его перхлорных экстрактов печени козы для изготовления лекарства для синергического лечения рака в комбинации со стандартными протоколами химиотерапии.2. The use of UK 114 protein or goat liver perchlore extracts containing it for the manufacture of a medicament for the synergistic treatment of cancer in combination with standard chemotherapy protocols. 3. Применение по п.2 в комбинации с 5-фторурацилом, циклофосфамидом и доксорубицином.3. The use according to claim 2 in combination with 5-fluorouracil, cyclophosphamide and doxorubicin. 4. Применение по п.2 или 3 для лечения карцином молочной железы.4. The use according to claim 2 or 3 for the treatment of breast carcinomas.
RU2005113167/15A 2002-10-30 2003-10-27 ANTI-TUMOR COMBINATIONS CONTAINING PROTEINS AND CHEMOTHERAPEUTIC MEDICINES RU2005113167A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI2002A002307 2002-10-30
IT002307A ITMI20022307A1 (en) 2002-10-30 2002-10-30 ANTI-TUMORAL ASSOCIATIONS INCLUDING PROTEINS AND CHEMOTHERAPIES.

Publications (1)

Publication Number Publication Date
RU2005113167A true RU2005113167A (en) 2005-11-20

Family

ID=32211391

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2005113167/15A RU2005113167A (en) 2002-10-30 2003-10-27 ANTI-TUMOR COMBINATIONS CONTAINING PROTEINS AND CHEMOTHERAPEUTIC MEDICINES

Country Status (8)

Country Link
KR (1) KR20050075761A (en)
CN (1) CN1708315A (en)
AU (1) AU2003285304A1 (en)
BR (1) BR0315813A (en)
IT (1) ITMI20022307A1 (en)
MX (1) MXPA05004514A (en)
RU (1) RU2005113167A (en)
WO (1) WO2004039393A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1244879B (en) * 1990-12-11 1994-09-12 Alberto Bartorelli EXTRACTS FROM ANIMAL TISSUES, USEFUL IN THERAPY AND DIAGNOSTICS.
US5283238A (en) * 1992-04-24 1994-02-01 Immtech International, Inc. Methods of treating cancer using modified C-reactive protein
IT1270618B (en) * 1994-07-14 1997-05-07 Zetesis Spa PROTEIN WITH ANTI-TUMOR ACTIVITY
ITMI991384A1 (en) * 1999-06-22 2000-12-22 Zetesis Spa USE OF UK 114 PROTEIN TO INHIBIT ORGAN TRANSPLANT REJECTION

Also Published As

Publication number Publication date
WO2004039393A1 (en) 2004-05-13
MXPA05004514A (en) 2005-07-26
AU2003285304A1 (en) 2004-05-25
KR20050075761A (en) 2005-07-21
BR0315813A (en) 2005-09-20
CN1708315A (en) 2005-12-14
ITMI20022307A1 (en) 2004-04-30

Similar Documents

Publication Publication Date Title
EP2517721A3 (en) Treatment of T-cell mediated diseases
ATE291438T1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ACUTE PAIN, CHRONIC PAIN AND/OR NEUROPATHIC PAIN AND MIGRAINES
GEP20063741B (en) Nonaryl-Heterocyclic NMDA/NR2B Antagonists
EP2269613A3 (en) Solid orald dosage form comprising a combination of metformin and glibenclamide
DE69000997D1 (en) RAPIDLY RELEASING ORAL PARTICULAR PHARMACEUTICAL PREPARATION WHICH MAKES UNPLEASANT TASTE MASKED.
DE59001556D1 (en) PREPARATIONS L-CARNITINE.
EE05286B1 (en) Crystalline comb form of the tert-but laminate salt of perindopril, process for its preparation and pharmaceutical compositions containing it
CL2004000930A1 (en) COMPOUND DERIVED FROM DEFINED FORMULA DIHYDROQUINAZOLINE, USEFUL FOR THE TREATMENT AND / OR PROFILAXIS OF VIRAL INFECTIONS; PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMPOUND AND USE OF THE COMPOUND IN THE PREPARATION OF MEDICINES.
NO20055838L (en) Active variants of IL-18 binding protein and medical applications thereof
EA200602047A1 (en) SULPHONYLETHYL PHOSPHORODYAMIDATES, INTENDED FOR USE IN CANCER TREATMENT
WO2005035485A3 (en) Analgesic compounds, their synthesis and pharmaceutical compositions containing them
IS2842B (en) Salt of perindopril and pharmaceutical preparations containing it. Drugs.
HK1068606A1 (en) Novel aminobenzoephenones
DE60336225D1 (en) NEW PHARMACEUTICAL COMPOSITIONS, FLIBERSERINE POLYMORPH A CONTAINING
CA2530613A1 (en) Rasgap derived peptide for selectively killing cancer cells
IL164464A0 (en) Antagonists to mcp proteins, their preparation, pharmaceutical composition containing them, and their use
JP2005530735A5 (en)
ATE293895T1 (en) FIBROUS LIPO NUTRITIONAL COMPLEXES AND COMPOSITIONS CONTAINING SAME
RU2005113167A (en) ANTI-TUMOR COMBINATIONS CONTAINING PROTEINS AND CHEMOTHERAPEUTIC MEDICINES
EP1801123A3 (en) Crystals of whole antibodies and fragments thereof and methods for making and using them
ATE210448T1 (en) MEDICINAL PREPARATION FOR ADMINISTRATION OF THIOCOLCHICOSIDE THROUGH THE ORAL MUCOSA
DE60008392D1 (en) NON-HYGROSCOPIC SALTS OF ACTIVE INGREDIENTS THAT HAVE THERAPEUTIC AND / OR NUTRITIONAL PROPERTIES AND ORAL ADMINISTRATIVE COMPOSITIONS CONTAINING THEM
IL161046A0 (en) Isogenic human cancer cells, methods utilizing the same for drug screening and discovery and pharmaceutical compositions containing cytidine analogs
Malara et al. Medicinal Plants from Brazilian Cerrado Biome: Potential sources of new anti-inflammatory compounds and antitumor agents on Ehrlich carcinoma
MD2053C2 (en) Remedy with interferon inducing action

Legal Events

Date Code Title Description
FA93 Acknowledgement of application withdrawn (no request for examination)

Effective date: 20061222